$ 1.7
-
2 of 5 dimensions have missing or inapplicable inputs and score 0. The total includes these dimensions.
This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
| Asset | Price | Div. Yield |
|---|